Gazprom Posts 29% Net Profit Growth 

Russian state gas giant PAO Gazprom said net profit for the second quarter was up 29% from the same period last year as a higher ruble price made up for lower sale volumes in its most-lucrative European market.

 
Valeant Strikes Psoriasis-Drug Pact With AstraZeneca 

Canada's Valeant Pharmaceuticals has struck a deal with AstraZeneca of the U.K. to develop and sell psoriasis treatment brodalumab.

 
India's Google Investigation Moves Forward 

Findings from the probe into Google's search practices have been submitted to India's antitrust watchdog.

 
Pension Funds Oppose Combined BofA Chairman, CEO Roles 

Two major public pension funds joined the drive for Bank of America Corp. shareholders to oppose a corporate bylaw change that lets Brian Moynihan serve as both chief executive and chairman.

 
American Renal Associates Files for IPO 

American Renal Associates Holdings Inc., the largest dialysis services provider in the U.S., has filed to go public.

 
Point72 Discloses Stake in SunEdison 

Billionaire Steven A. Cohen's investment firm Point72 Asset Management LP on Monday disclosed a 5.1% stake in renewable-energy developer SunEdison Inc.

 
NovoCure Files for IPO 

NovoCure Ltd., which makes a device that uses electrical fields to fight a common form of brain cancer, has disclosed plans for an initial public offering.

(END) Dow Jones Newswires

September 01, 2015 06:20 ET (10:20 GMT)

Copyright (c) 2015 Dow Jones & Company, Inc.